ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC79.31

C79.31

Billable

Secondary malignant neoplasm of brain

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C79.31 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of brain.

Key Diagnostic Point:

C79.31 refers to secondary malignant neoplasms of the brain, which are metastatic tumors that have spread to the brain from a primary cancer located elsewhere in the body. These tumors can arise from various primary sites, including the lungs, breasts, kidneys, and melanoma. The clinical presentation may vary widely, with symptoms often including headaches, seizures, cognitive changes, and focal neurological deficits. Diagnosis typically involves imaging studies such as MRI or CT scans, which can reveal the presence of lesions in the brain. Treatment options may include surgery, radiation therapy, and chemotherapy, depending on the extent of the disease and the patient's overall health. Staging of metastatic brain tumors is crucial for determining prognosis and treatment strategies, often classified using the Karnofsky Performance Status or the Eastern Cooperative Oncology Group (ECOG) scale. Palliative care considerations are essential, focusing on symptom management and quality of life, especially in advanced stages of the disease where curative treatment may not be feasible.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Determining the primary site of cancer can be challenging.
  • Documentation must clearly indicate the metastatic nature of the neoplasm.
  • Staging information is often required for accurate coding.
  • Differentiating between primary brain tumors and secondary tumors requires careful review.

Audit Risk Factors

  • Inadequate documentation of the primary cancer site.
  • Failure to document the metastatic nature of the tumor.
  • Incorrect staging information.
  • Misclassification of primary versus secondary tumors.

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed history of the primary cancer, treatment history, and current status of the metastatic disease.

Common Clinical Scenarios

Patients with known primary cancers presenting with neurological symptoms.

Billing Considerations

Ensure that the primary site is documented and that the metastatic nature is clearly stated.

Neurology

Documentation Requirements

Neurological examination findings, imaging results, and treatment plans.

Common Clinical Scenarios

Patients presenting with seizures or cognitive decline with a known history of cancer.

Billing Considerations

Document neurological deficits and their relation to the metastatic disease.

Coding Guidelines

Inclusion Criteria

Use C79.31 When
  • According to ICD
  • 10 coding guidelines, C79
  • 31 should be used when there is clear documentation of a secondary malignant neoplasm of the brain
  • It is important to ensure that the primary site is identified and documented, as this affects treatment and prognosis

Exclusion Criteria

Do NOT use C79.31 When
  • Exclusion criteria include primary brain tumors, which should be coded separately

Related ICD-10 Codes

Related CPT Codes

77263CPT Code

Radiation treatment delivery, 3D conformal technique

Clinical Scenario

Used for patients receiving radiation therapy for brain metastases.

Documentation Requirements

Documentation of treatment plan and tumor location.

Specialty Considerations

Oncology specialists should ensure accurate coding based on treatment intent.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of secondary malignant neoplasms, improving the accuracy of data collection and reimbursement processes. C79.31 provides a clear distinction between primary and secondary tumors, which is essential for treatment planning and research.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of secondary malignant neoplasms, improving the accuracy of data collection and reimbursement processes. C79.31 provides a clear distinction between primary and secondary tumors, which is essential for treatment planning and research.

Reimbursement & Billing Impact

reimbursement processes. C79.31 provides a clear distinction between primary and secondary tumors, which is essential for treatment planning and research.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between primary and secondary malignant neoplasms of the brain?

Primary malignant neoplasms originate in the brain tissue itself, while secondary malignant neoplasms, such as C79.31, are metastatic tumors that have spread to the brain from other parts of the body.